Freenome, Inc.(FRNM)

Medical - Diagnostics & Research · Brisbane, CA

$16.98+0.15 (+0.86%)

Delayed quote: Oct 6, 2026, 10:10 AM EDT

EV/EBITDA Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T14:12:00.063Z.

Stored calculation inputs

Calculation as of: 2026-10-06T14:12:00.063Z.

Quote observation: 2026-10-06T14:10:01.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 138,469,183
Total debt: N/A
Cash: N/A
TTM operating EBITDA: N/A

FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840

EV/Sales|P/E Ratio|EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

FRNM EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

FRNM Competitors' EV/EBITDA Ratio

FRNM

Freenome, Inc.

Current

Market Cap

$138.47M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KRMD

KORU Medical Systems, Inc.

vs FRNM

Market Cap

$137.57M

EV/EBITDA Ratio

N/A

TTM Avg

693.21x

3Y Avg

347.06x

5Y Avg

258.50x

ACOG

Alpha Cognition Inc

vs FRNM

Market Cap

$140.09M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AIRS

AirSculpt Technologies, Inc.

vs FRNM

Market Cap

$139.95M

EV/EBITDA Ratio

450.81x

TTM Avg

352.35x

3Y Avg

117.66x

5Y Avg

91.76x

LFMD

LifeMD, Inc.

vs FRNM

Market Cap

$135.83M

EV/EBITDA Ratio

N/A

TTM Avg

53.44x

3Y Avg

53.44x

5Y Avg

53.44x

FBIOP

Fortress Biotech, Inc.

vs FRNM

Market Cap

$141.70M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IMRX

Immuneering Corporation

vs FRNM

Market Cap

$144.79M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HCAT

Health Catalyst, Inc.

vs FRNM

Market Cap

$131.16M

EV/EBITDA Ratio

74.50x

TTM Avg

73.16x

3Y Avg

73.16x

5Y Avg

73.16x

KRSA

Korsana Biosciences, Inc.

vs FRNM

Market Cap

$146.71M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ABOS

Acumen Pharmaceuticals, Inc.

vs FRNM

Market Cap

$148.07M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
Freenome, Inc. (FRNM)	$138.47M	N/A	N/A	N/A	N/A
KORU Medical Systems, Inc. (KRMD)vs ›	$137.57M	N/A	693.21x	347.06x	258.50x
Alpha Cognition Inc (ACOG)vs ›	$140.09M	N/A	N/A	N/A	N/A
AirSculpt Technologies, Inc. (AIRS)vs ›	$139.95M	450.81x	352.35x	117.66x	91.76x
LifeMD, Inc. (LFMD)vs ›	$135.83M	N/A	53.44x	53.44x	53.44x
Fortress Biotech, Inc. (FBIOP)vs ›	$141.70M	N/A	N/A	N/A	N/A
Immuneering Corporation (IMRX)vs ›	$144.79M	N/A	N/A	N/A	N/A
Health Catalyst, Inc. (HCAT)vs ›	$131.16M	74.50x	73.16x	73.16x	73.16x
Korsana Biosciences, Inc. (KRSA)vs ›	$146.71M	N/A	N/A	N/A	N/A
Acumen Pharmaceuticals, Inc. (ABOS)vs ›	$148.07M	N/A	N/A	N/A	N/A

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics